Subscribe to our Email Alerts

Island Pharmaceuticals
  • About Us
    • Island at a glance
    • Board
    • Key Management
    • Scientific Advisory Board
    • Collaborations
  • Science
    • About ISLA-101
    • Scientific Publications
    • Drug repurposing and benefits
  • Investor Centre
    • Investor Welcome
      • Clinical programme
    • ASX Announcements
    • Financial Reports
    • Share Price Information
    • Shareholder Services
    • Investor Fact Sheet
    • Corporate Governance
    • Corporate Directory
    • International Investors
    • Research Coverage
    • AGM
  • Media
    • News
    • Presentations
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
Investor Centre
Investor Centre > Research Coverage
  • Investor Welcome
    • Clinical programme
  • ASX Announcements
  • Financial Reports
  • Share Price Information
  • Shareholder Services
  • Investor Fact Sheet
  • Corporate Governance
  • Corporate Directory
  • International Investors
  • Research Coverage
  • AGM

Research Coverage


 
11-Jan-2023    MST Access: IND submission starts the clock  
 
22-Dec-2022    MST Access: Phase 2a trial on track for early CY23  
 
25-Nov-2022    MST Access: Trial to start early CY23  
 
27-Jul-2022    MST Access initiates research coverage on Island Pharmaceuticals  
 

Quick Links

Contact Us

Island Pharmaceuticals
Suite 201, 697 Burke Road
Camberwell, Victoria 3124

info@islandpharmaceuticals.com

www.islandpharmaceuticals.com

Email Alerts

Which of the following group do you best fit?

 

Follow Us

Follow Us

Site Map Privacy Search
Copyright © Island Pharmaceuticals
Site Map Privacy Search
Site by